ClinConnect ClinConnect Logo
Search / Trial NCT05355012

Organization of Smoking Cessation in Pregnant Women With the Implementation of the 5A Strategy in New Aquitaine.

Launched by UNIVERSITY HOSPITAL, BORDEAUX · Apr 25, 2022

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

Smoking Cessation Pregnancy 5 As Healthcare Optimization Transferability Healthcare Sustainability Organizational Innovation

ClinConnect Summary

This clinical trial is studying a program called the 5A-QUIT-N strategy, which aims to help pregnant women in New Aquitaine quit smoking. The goal is to see how effective this program is in supporting women who smoke during their pregnancy and to find out what makes it work best. The trial is looking for different groups of people to participate, including healthcare professionals, individuals involved in the implementation of the program, and women who have recently given birth and smoked during their pregnancy. To be eligible, women must have smoked at least twice a week during their pregnancy, have given birth in a New Aquitaine hospital, and be over 18 years old.

Participants can expect to be part of a supportive environment where their experiences and feedback will help shape the effectiveness of this smoking cessation program. They will be asked to provide information about their smoking habits and any support they received during their pregnancy. It’s important to note that women who only use electronic cigarettes, do not speak French, or have certain health conditions may not be eligible for this study. Overall, the trial aims to improve resources for pregnant women wanting to quit smoking, benefiting both mothers and their babies.

Gender

ALL

Eligibility criteria

  • In this research, there are 4 categories of research participants:
  • Healthcare professionals: the target of the 5A-QUIT-N intervention from whom data will be collected to meet the secondary objective of the effectiveness conditions.
  • Stakeholders: individuals involved in the implementation of the research and intervention from whom data will be collected to meet the secondary objective of the effectiveness conditions.
  • Women who have just given birth and who smoke tobacco in early pregnancy: indirect beneficiaries of the intervention, from whom data will be collected to meet the primary objective of effectiveness.
  • Co-parent (partner) of the new-born child of the woman who has just given birth included in the study
  • Inclusion criteria for the intervention
  • The inclusion criteria for the clusters are :
  • - Territory of maternity attractiveness in New Aquitaine
  • The inclusion criteria for care providers within the clusters are:
  • All institutions, structures and organizations and health professionals likely to participate in the follow-up of pregnant women
  • All institutions, structures and organizations and health professionals specializing in addictology or tobaccoology
  • The inclusion criteria for pregnant women within the clusters are :
  • - All pregnant women who have smoked tobacco (at least 2 times a week, for at least 1 week) during the pregnancy (including the period when she was unaware of the pregnancy)
  • Inclusion criteria for the primary objective measures:
  • The inclusion criteria for women are (for data collection):
  • Have given birth in a New Aquitaine maternity hospital,
  • Reside in New Aquitaine
  • To have been followed for the pregnancy in the territory of the maternity of delivery
  • To have used tobacco during (at least 2 times a week, for at least 1 week) the pregnancy (including the period when she was unaware of the pregnancy)
  • Be over 18
  • Have given free, informed and express consent
  • * Exclusion criteria:
  • Non-inclusion criteria for the intervention
  • Cluster non-inclusion criteria:
  • Pilot territory (territory of attractiveness of the Arcachon maternity hospital)
  • Impossibility of collecting the main judgment criterion in the cluster Within these clusters, the health care providers and the pregnant women are all concerned and therefore do not have any non-inclusion criteria.
  • Non-inclusion criteria of measures for the primary objective:
  • The criteria for non-inclusion of women who have just given birth are:
  • Not speaking French,
  • Have COVID during delivery
  • Use only electronic cigarettes,
  • Under legal protection (guardianship, curatorship, safeguard of justice)
  • Women giving birth under X
  • Women giving birth to a stillborn baby
  • Women having made a denial of pregnancy
  • Women who have their child in neonatal intensive care
  • Women who have been fully monitored for their pregnancy outside of New Aquitaine

About University Hospital, Bordeaux

The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.

Locations

Bordeaux, , France

Patients applied

0 patients applied

Trial Officials

François Alla, Prof

Principal Investigator

University Hospital, Bordeaux

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials